Article
SPARC Promotes Aerobic Glycolysis and 5‐Fluorouracil Resistance in Colorectal Cancer Through the STAT3 / HK2 Axis
25 May 2025
Abstract excerpt
BACKGROUND: Chemotherapy has been used extensively in the clinic to treat colorectal cancer (CRC). Nevertheless, cancer cells usually develop chemoresistance under chemotherapy stress, leading to treatment failure. At present, the mechanism of chemoresistance in patients with CRC is not fully understood. METHODS: Firstly, Secreted protein acidic and rich in cysteine (SPARC) expression and prognosis in CRC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
